Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
ACE Monoclonal Antibody (230214), Invitrogen™
Rat Monoclonal Antibody
Supplier: Thermo Scientific MA523939
Description
Reconstitute at 0.5 mg/mL in sterile PBS.
ACE Monoclonal antibody specifically detects ACE in Mouse samples. It is validated for Flow Cytometry, Immunoprecipitation.Specifications
ACE | |
Monoclonal | |
0.5 mg/mL | |
PBS with 5% trehalose and No Preservative | |
P09470 | |
Ace | |
Mouse myeloma cell line NS0-derived recombinant mouse ACE/CD143 (aa 35-1264) | |
100 μg | |
Primary | |
Mouse | |
Antibody | |
IgG2a |
Flow Cytometry, Immunoprecipitation | |
230214 | |
Unconjugated | |
Ace | |
ACE; ACE1; ACE-T; angiotensin 1 converting enzyme 1; angiotensin converting enzyme; angiotensin converting enzyme, somatic isoform; angiotensin I converting enzyme; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1; angiotensin I converting enzyme 1; angiotensin I converting enzyme peptidyl-dipeptidase A 1 transcript; angiotensin I-converting enzyme (Dipeptidyl carboxypeptidase 1); angiotensin-converting enzyme; Angiotensin-converting enzyme, soluble form; angiotensin-converting enzyme; LOW QUALITY PROTEIN: angiotensin-converting enzyme; angiotensin-converting enzyme-like; AW208573; carboxycathepsin; CD143; CD143 antigen; DCP; Dcp1; dipeptidyl carboxypeptidase 1; Dipeptidyl carboxypeptidase 1 (Angiotensin I-converting enzyme); dipeptidyl carboxypeptidase I; dipeptidyl peptidase; I79_009670; ICH; kininase II; LOC103158533; MGC26566; MVCD3; peptidase P; peptidyl dipeptidase i; StsRR92; testicular ECA | |
Rat | |
Protein A/G | |
RUO | |
11421 | |
-20° C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction